• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Low eukaryotic viral richness is associated with faecal microbiota transplantation success in patients with UC.

作者信息

Conceição-Neto Nádia, Deboutte Ward, Dierckx Tim, Machiels Kathleen, Wang Jun, Yinda Kwe Claude, Maes Piet, Van Ranst Marc, Joossens Marie, Raes Jeroen, Vermeire Séverine, Matthijnssens Jelle

机构信息

Department of Microbiology and Immunology, KU Leuven-University of Leuven, Laboratory of Viral Metagenomics, Rega Institute, Leuven, Belgium.

Department of Microbiology and Immunology, KU Leuven-University of Leuven, Laboratory of Clinical Virology, Rega Institute, Leuven, Belgium.

出版信息

Gut. 2018 Aug;67(8):1558-1559. doi: 10.1136/gutjnl-2017-315281. Epub 2017 Oct 24.

DOI:10.1136/gutjnl-2017-315281
PMID:29066574
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6204959/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8815/6204959/b716577c14c2/gutjnl-2017-315281f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8815/6204959/69dca915a82d/gutjnl-2017-315281f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8815/6204959/b716577c14c2/gutjnl-2017-315281f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8815/6204959/69dca915a82d/gutjnl-2017-315281f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8815/6204959/b716577c14c2/gutjnl-2017-315281f02.jpg

相似文献

1
Low eukaryotic viral richness is associated with faecal microbiota transplantation success in patients with UC.低真核病毒丰富度与溃疡性结肠炎患者粪便微生物群移植的成功相关。
Gut. 2018 Aug;67(8):1558-1559. doi: 10.1136/gutjnl-2017-315281. Epub 2017 Oct 24.
2
Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease.供体物种丰富度决定炎症性肠病中粪便微生物群移植的成功率。
J Crohns Colitis. 2016 Apr;10(4):387-94. doi: 10.1093/ecco-jcc/jjv203. Epub 2015 Oct 29.
3
Long-term Multidonor Faecal Microbiota Transfer by Oral Capsules for Active Ulcerative Colitis.口服胶囊长期多供体粪便微生物群移植治疗活动期溃疡性结肠炎
J Crohns Colitis. 2019 Oct 28;13(11):1480-1481. doi: 10.1093/ecco-jcc/jjz073.
4
Editorial: faecal microbiota transplantation for ulcerative colitis-not quite there yet?社论：粪便微生物群移植治疗溃疡性结肠炎——尚未完全实现？
Aliment Pharmacol Ther. 2017 Sep;46(6):630-631. doi: 10.1111/apt.14228.
5
Editorial: faecal microbiota transplantation for ulcerative colitis-not quite there yet? Authors' reply.社论：粪便微生物群移植治疗溃疡性结肠炎——尚未完全实现？作者回复。
Aliment Pharmacol Ther. 2017 Sep;46(6):631-632. doi: 10.1111/apt.14246.
6
Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.复发性艰难梭菌感染和/或溃疡性结肠炎患者单次供体粪便微生物群移植的纵向微生物组分析
PLoS One. 2018 Jan 31;13(1):e0190997. doi: 10.1371/journal.pone.0190997. eCollection 2018.
7
[Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial].[多供体强化粪便微生物群移植治疗活动性溃疡性结肠炎：一项随机安慰剂对照试验]
Z Gastroenterol. 2017 Aug;55(8):779-780. doi: 10.1055/s-0043-109349. Epub 2017 Aug 10.
8
[Faecal microbiota transplantation: indications in perspective].[粪便微生物群移植：前景中的适应症]
Ned Tijdschr Geneeskd. 2017;161:D1623.
9
Response to faecal microbiota transplantation in ulcerative colitis is not sustained long term following induction therapy.溃疡性结肠炎患者在诱导治疗后，粪便微生物群移植的反应无法长期维持。
Gut. 2021 Nov;70(11):2210-2211. doi: 10.1136/gutjnl-2020-323581. Epub 2020 Dec 10.
10
[Faecal transplantation as a treatment for Clostridium difficile infection, ulcerative colitis and the metabolic syndrome].[粪便移植作为艰难梭菌感染、溃疡性结肠炎和代谢综合征的一种治疗方法]
Ugeskr Laeger. 2014 Feb 17;176(4).

引用本文的文献

1
The gut virome in association with the bacteriome in gastrointestinal diseases and beyond: roles, mechanisms, and clinical applications.胃肠道疾病及其他情况下与细菌群落相关的肠道病毒组：作用、机制及临床应用
Precis Clin Med. 2025 May 28;8(2):pbaf010. doi: 10.1093/pcmedi/pbaf010. eCollection 2025 Jun.
2
Alterations of the Enteric Virome in Vogt-Koyanagi-Harada Disease.伏格特-小柳-原田病中肠道病毒组的改变
Invest Ophthalmol Vis Sci. 2025 Jun 2;66(6):15. doi: 10.1167/iovs.66.6.15.
3
Virome drift in ulcerative colitis patients: faecal microbiota transplantation results in minimal phage engraftment dominated by microviruses.

本文引用的文献

1
Bacteriophage transfer during faecal microbiota transplantation in infection is associated with treatment outcome.在感染期间，粪便微生物群移植过程中的噬菌体转移与治疗结果相关。
Gut. 2018 Apr;67(4):634-643. doi: 10.1136/gutjnl-2017-313952. Epub 2017 May 24.
2
European consensus conference on faecal microbiota transplantation in clinical practice.临床实践中粪便微生物群移植欧洲共识会议
Gut. 2017 Apr;66(4):569-580. doi: 10.1136/gutjnl-2016-313017. Epub 2017 Jan 13.
3
Modular approach to customise sample preparation procedures for viral metagenomics: a reproducible protocol for virome analysis.
溃疡性结肠炎患者的病毒组漂移：粪便微生物群移植导致以微小病毒为主的噬菌体植入极少。
Gut Microbes. 2025 Dec;17(1):2499575. doi: 10.1080/19490976.2025.2499575. Epub 2025 May 15.
4
The phageome of patients with ulcerative colitis treated with donor fecal microbiota reveals markers associated with disease remission.溃疡性结肠炎患者接受供体粪便微生物群治疗后的噬菌体组揭示了与疾病缓解相关的标志物。
Nat Commun. 2024 Oct 17;15(1):8979. doi: 10.1038/s41467-024-53454-4.
5
Past, present, and future of microbiome-based therapies.基于微生物群的疗法的过去、现在和未来。
Microbiome Res Rep. 2024 Mar 18;3(2):23. doi: 10.20517/mrr.2023.80. eCollection 2024.
6
Fecal microbiota transplantation: current challenges and future landscapes.粪便微生物群移植：当前的挑战和未来的前景。
Clin Microbiol Rev. 2024 Jun 13;37(2):e0006022. doi: 10.1128/cmr.00060-22. Epub 2024 May 8.
7
IPEV: identification of prokaryotic and eukaryotic virus-derived sequences in virome using deep learning.IPEV：利用深度学习在病毒组中鉴定原核生物和真核生物病毒序列。
Gigascience. 2024 Jan 2;13. doi: 10.1093/gigascience/giae018.
8
The gut ileal mucosal virome is disturbed in patients with Crohn's disease and exacerbates intestinal inflammation in mice.肠回肠黏膜病毒组在克罗恩病患者中受到干扰，并在小鼠中加剧肠道炎症。
Nat Commun. 2024 Feb 22;15(1):1638. doi: 10.1038/s41467-024-45794-y.
9
The Evolving Landscape of Fecal Microbial Transplantation.粪便微生物移植的演变格局。
Clin Rev Allergy Immunol. 2023 Oct;65(2):101-120. doi: 10.1007/s12016-023-08958-0. Epub 2023 Feb 9.
10
Fecal microbiota transplantation treatment of autoimmune-mediated type 1 diabetes: A systematic review.粪便微生物群移植治疗自身免疫介导的 1 型糖尿病：系统评价。
Front Cell Infect Microbiol. 2022 Dec 1;12:1075201. doi: 10.3389/fcimb.2022.1075201. eCollection 2022.
用于定制病毒宏基因组学样本制备程序的模块化方法：病毒群落分析的可重复方案
Sci Rep. 2015 Nov 12;5:16532. doi: 10.1038/srep16532.
4
Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease.供体物种丰富度决定炎症性肠病中粪便微生物群移植的成功率。
J Crohns Colitis. 2016 Apr;10(4):387-94. doi: 10.1093/ecco-jcc/jjv203. Epub 2015 Oct 29.
5
Origins and evolution of viruses of eukaryotes: The ultimate modularity.真核生物病毒的起源与进化：终极模块化
Virology. 2015 May;479-480:2-25. doi: 10.1016/j.virol.2015.02.039. Epub 2015 Mar 12.
6
Disease-specific alterations in the enteric virome in inflammatory bowel disease.炎症性肠病中肠道病毒组的疾病特异性改变。
Cell. 2015 Jan 29;160(3):447-60. doi: 10.1016/j.cell.2015.01.002. Epub 2015 Jan 22.
7
Fecal microbiota transplantation in the treatment of Clostridium difficile infections.粪便微生物群移植治疗艰难梭菌感染。
Am J Med. 2014 Jun;127(6):479-83. doi: 10.1016/j.amjmed.2014.02.017. Epub 2014 Feb 26.
8
Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation.粪便微生物移植后溃疡性结肠炎患者的时间细菌群落动态变化存在差异。
Am J Gastroenterol. 2013 Oct;108(10):1620-30. doi: 10.1038/ajg.2013.257. Epub 2013 Sep 24.
9
Duodenal infusion of donor feces for recurrent Clostridium difficile.经十二指肠输注供体粪便治疗复发性艰难梭菌感染。
N Engl J Med. 2013 Jan 31;368(5):407-15. doi: 10.1056/NEJMoa1205037. Epub 2013 Jan 16.